Stifel Shows Optimism for Aclaris Therapeutics, Inc. (ACRS) as a Notable Penny Stock
Aclaris Therapeutics, Inc. (ACRS) is attracting interest as a notable penny stock, with Stifel indicating a positive outlook on its future potential.
Editorial Staff
1 min read
Updated 2 days ago
Aclaris Therapeutics, Inc. (ACRS) has recently emerged as a penny stock that is gaining traction among investors.
Stifel, a prominent financial services firm, has expressed a bullish stance on Aclaris, highlighting its potential in the market.
As investors look for promising opportunities, Aclaris may be worth considering for those interested in penny stocks.